CommentaryFrom SARS-CoV-2 to analgesia: harnessing the vascular endothelial growth factor A/neuropilin 1 axis for pain therapyMustafá, Emilio R.; Weiss, Norbert Author Information Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. PAIN 164(7):p 1403-1405, July 2023. | DOI: 10.1097/j.pain.0000000000002851 Buy Metrics © 2023 International Association for the Study of Pain
